Clinical & translational oncology

• 

  Año 2007, Vol. 9, Número 5

  • Centralisation of complex pathologies in honours of excellence. How to do it?

    V. Javier Escrig Sos

    págs. 267-268

    

  • High tension:oncologic pain

    Enrique García Jordá

    págs. 269-271

    

  • Molecular determinants of invasion in endometrial cancer

    Miguel Abal Posada

    págs. 272-277

    

  • Hypoxia-inducible factors and cancer

    M.J Calzada, L. del Peso

    págs. 278-289

    

  • Cancer epidemiology:study designs and data analysis

    Núria Malats Riera, Gemma Castaño Vinyals

    págs. 290-297

    

  • Oxycodone: a pharmacological and clinical review

    Amalio Ordóñez Gallego, Manuel Gonzalez Barón, E. Espinosa Arranz

    págs. 298-307

    

  • Treatment guidelines in ovarian cancer

    Alaitz Poveda Zabala

    págs. 308-316

    

  • Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and and cyclophosphamide therapy in stage II and III breast cancer patiens: results of a phase II study

    Pedro Sánchez Rovira

    págs. 317-322

    

  • Long-term outcome of a phase II study of weely docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patiens

    Antonio González Martín

    págs. 323-328

    

  • Non-seminomatous germ-cell tumour asociated with acute megakaryoblastic leukaemia

    M.I. Gallegos Sancho

    págs. 329-331

    

  • False-positive B-human chorionic gonadotropin values in the follow-up of gestational trophoblastic disease

    V. M. Díaz Muñoz de la Espada

    págs. 332-334

    

  • Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma

    Coralia Bueno Muiño

    págs. 335-338